Skip to main content
Top
Published in: BMC Musculoskeletal Disorders 1/2016

Open Access 01-12-2016 | Research article

Local pamidronate influences fracture healing in a rodent femur fracture model: an experimental study

Authors: Leif Menzdorf, Matthias Weuster, Tim Klüter, Stefan Brüggemann, Peter Behrendt, Stefanie Fitchen-Oestern, Deike Varoga, Andreas Seekamp, Nicolai Purcz, Claus C Glueer, Thomas Pufe, Sebastian Lippross

Published in: BMC Musculoskeletal Disorders | Issue 1/2016

Login to get access

Abstract

Background

Bisphosphonates are a main component in the therapy of osteoporosis and other bone resorptive diseases. Previous studies have shown a positive effect of systemically applied bisphosphonates on fracture healing. Nevertheless high doses are related to side effects like osteonecrosis of the jaw, nephrotoxis and gastrointestinal symptoms. In this study we investigated the effect of locally applied pamidronate on fracture healing.

Methods

In a rodent model a simple femur fracture was set in female Wistar rats. We performed intramedullary fixation of the fracture and placed a collagen matrix around the fracture area. One group was treated with pamidronate, the other group with placebo via the matrix.
To investigate the volume and quality of the callus we used micro-CT (μCT) and histology after 14 and 28 days.

Results

Our results show a positive influence of local applied pamidronate on callus volume. After 14 days an insignificant increase of callus volume in the treated animals was seen. 28 days after trauma the increase of callus volume in the treatment group was significantly higher in comparison to the control group. Osteonecrosis was not seen.

Conclusions

Locally applied bisphosphonates increase the callus volume in fracture healing.
Literature
1.
go back to reference Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008;10(2):92–6.CrossRefPubMed Cole ZA, Dennison EM, Cooper C. Osteoporosis epidemiology update. Curr Rheumatol Rep. 2008;10(2):92–6.CrossRefPubMed
2.
go back to reference Becker S, Ogon M. Epidemiology of osteoporosis. In: Balloon Kyphoplasty. 2008. p. 1–3.CrossRef Becker S, Ogon M. Epidemiology of osteoporosis. In: Balloon Kyphoplasty. 2008. p. 1–3.CrossRef
3.
go back to reference Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.CrossRefPubMed Kanis JA, Melton 3rd LJ, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res. 1994;9(8):1137–41.CrossRefPubMed
4.
go back to reference Towne Jr SD, Smith ML, Yoshikawa A, Ory MG. Geospatial distribution of fall-related hospitalization incidence in Texas. J Safety Res. 2015;53:11–6.CrossRefPubMed Towne Jr SD, Smith ML, Yoshikawa A, Ory MG. Geospatial distribution of fall-related hospitalization incidence in Texas. J Safety Res. 2015;53:11–6.CrossRefPubMed
6.
go back to reference Riggs BL, Melton 3rd LJ. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327(9):620–7.CrossRefPubMed Riggs BL, Melton 3rd LJ. The prevention and treatment of osteoporosis. N Engl J Med. 1992;327(9):620–7.CrossRefPubMed
7.
go back to reference Reno F, Rizzi M, Invernizzi M, Migliario M, Cisari C. Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor. Eur J Pharmacol. 2013;721(1-3):301–4.CrossRefPubMed Reno F, Rizzi M, Invernizzi M, Migliario M, Cisari C. Low doses amino-bisphosphonates stimulate keratinocytes growth inactivating glucocorticoid receptor. Eur J Pharmacol. 2013;721(1-3):301–4.CrossRefPubMed
8.
go back to reference Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Oppermann U. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A. 2006;103(20):7829–34.CrossRefPubMedPubMedCentral Kavanagh KL, Guo K, Dunford JE, Wu X, Knapp S, Ebetino FH, Rogers MJ, Russell RG, Oppermann U. The molecular mechanism of nitrogen-containing bisphosphonates as antiosteoporosis drugs. Proc Natl Acad Sci U S A. 2006;103(20):7829–34.CrossRefPubMedPubMedCentral
9.
go back to reference Dunford JE. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition. Curr Pharm Des. 2010;16(27):2961–9.CrossRefPubMed Dunford JE. Molecular targets of the nitrogen containing bisphosphonates: the molecular pharmacology of prenyl synthase inhibition. Curr Pharm Des. 2010;16(27):2961–9.CrossRefPubMed
10.
go back to reference Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour- induced hypercalcaemic and metastatic bone disease. Drugs. 1991;42:919–44.CrossRefPubMed Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour- induced hypercalcaemic and metastatic bone disease. Drugs. 1991;42:919–44.CrossRefPubMed
11.
go back to reference Amanat N, Brown R, Bilston LE, Little DG. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res. 2005;23(5):1029–34.CrossRefPubMed Amanat N, Brown R, Bilston LE, Little DG. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res. 2005;23(5):1029–34.CrossRefPubMed
12.
go back to reference Elliott SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. 1998;62(1):77–91.CrossRefPubMed Elliott SN, McKnight W, Davies NM, MacNaughton WK, Wallace JL. Alendronate induces gastric injury and delays ulcer healing in rodents. Life Sci. 1998;62(1):77–91.CrossRefPubMed
13.
go back to reference Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone. 2008;42(2):365–71.CrossRefPubMed Wermelin K, Suska F, Tengvall P, Thomsen P, Aspenberg P. Stainless steel screws coated with bisphosphonates gave stronger fixation and more surrounding bone. Histomorphometry in rats. Bone. 2008;42(2):365–71.CrossRefPubMed
14.
go back to reference Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G. Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop. 2008;79(5):717–25.CrossRefPubMed Greiner SH, Wildemann B, Back DA, Alidoust M, Schwabe P, Haas NP, Schmidmaier G. Local application of zoledronic acid incorporated in a poly(D, L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop. 2008;79(5):717–25.CrossRefPubMed
15.
go back to reference Gabet Y, Muller R, Regev E, Sela J, Shteyer A, Salisbury K, Chorev M, Bab I. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone. 2004;35(1):65–73.CrossRefPubMed Gabet Y, Muller R, Regev E, Sela J, Shteyer A, Salisbury K, Chorev M, Bab I. Osteogenic growth peptide modulates fracture callus structural and mechanical properties. Bone. 2004;35(1):65–73.CrossRefPubMed
16.
go back to reference Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2:97–101.CrossRefPubMed Bonnarens F, Einhorn TA. Production of a standard closed fracture in laboratory animal bone. J Orthop Res. 1984;2:97–101.CrossRefPubMed
17.
go back to reference Grongroft I, Heil P, Matthys R, Lezuo P, Tami A, Perren S, Montavon P, Ito K. Fixation compliance in a mouse osteotomy model induces two different processes of bone healing but does not lead to delayed union. J Biomech. 2009;42(13):2089–96.CrossRefPubMed Grongroft I, Heil P, Matthys R, Lezuo P, Tami A, Perren S, Montavon P, Ito K. Fixation compliance in a mouse osteotomy model induces two different processes of bone healing but does not lead to delayed union. J Biomech. 2009;42(13):2089–96.CrossRefPubMed
18.
go back to reference Goodship AE, Walker PC, McNally D, Chambers T, Green JR. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5 Suppl 7:S53–5.PubMed Goodship AE, Walker PC, McNally D, Chambers T, Green JR. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994;5 Suppl 7:S53–5.PubMed
19.
go back to reference Nyman MT, Paavolainen P, Lindholm TS. Clodronate increases the calcium content in fracture callus. An experimental study in rats. Arch Orthop Trauma Surg. 1993;112(5):228–31.CrossRefPubMed Nyman MT, Paavolainen P, Lindholm TS. Clodronate increases the calcium content in fracture callus. An experimental study in rats. Arch Orthop Trauma Surg. 1993;112(5):228–31.CrossRefPubMed
20.
go back to reference Li J, Mori S, Kaji Y, Kawanishi J, Akiyama T, Norimatsu H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J Bone Miner Res. 2000;15(10):2042–51.CrossRefPubMed Li J, Mori S, Kaji Y, Kawanishi J, Akiyama T, Norimatsu H. Concentration of bisphosphonate (incadronate) in callus area and its effects on fracture healing in rats. J Bone Miner Res. 2000;15(10):2042–51.CrossRefPubMed
21.
go back to reference Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16(3):429–36.CrossRefPubMed Li C, Mori S, Li J, Kaji Y, Akiyama T, Kawanishi J, Norimatsu H. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16(3):429–36.CrossRefPubMed
22.
go back to reference Villa A, Castiglioni S, Peretti A, Omodei M, Ferrieri GB, Abati S. Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone. ISRN Rheumatol. 2011;2011:654027.CrossRefPubMedPubMedCentral Villa A, Castiglioni S, Peretti A, Omodei M, Ferrieri GB, Abati S. Osteoporosis and bisphosphonate-related osteonecrosis of the jaw bone. ISRN Rheumatol. 2011;2011:654027.CrossRefPubMedPubMedCentral
23.
24.
go back to reference Hyldstrup L, Flesch G, Hauffe SA. Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcif Tissue Int. 1993;53(5):297–300.CrossRefPubMed Hyldstrup L, Flesch G, Hauffe SA. Pharmacokinetic evaluation of pamidronate after oral administration: a study on dose proportionality, absolute bioavailability, and effect of repeated administration. Calcif Tissue Int. 1993;53(5):297–300.CrossRefPubMed
26.
go back to reference Komatsubara S, Mori S, Mashiba T, Li J, Nonaka K, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanishi J, et al. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res. 2004;19(6):999–1005.CrossRefPubMed Komatsubara S, Mori S, Mashiba T, Li J, Nonaka K, Kaji Y, Akiyama T, Miyamoto K, Cao Y, Kawanishi J, et al. Suppressed bone turnover by long-term bisphosphonate treatment accumulates microdamage but maintains intrinsic material properties in cortical bone of dog rib. J Bone Miner Res. 2004;19(6):999–1005.CrossRefPubMed
Metadata
Title
Local pamidronate influences fracture healing in a rodent femur fracture model: an experimental study
Authors
Leif Menzdorf
Matthias Weuster
Tim Klüter
Stefan Brüggemann
Peter Behrendt
Stefanie Fitchen-Oestern
Deike Varoga
Andreas Seekamp
Nicolai Purcz
Claus C Glueer
Thomas Pufe
Sebastian Lippross
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Musculoskeletal Disorders / Issue 1/2016
Electronic ISSN: 1471-2474
DOI
https://doi.org/10.1186/s12891-016-1113-9

Other articles of this Issue 1/2016

BMC Musculoskeletal Disorders 1/2016 Go to the issue